FDA Releases Guidance on Reporting Fatalities Related to Blood Collection and Transfusion

Summary

The Food and Drug Administration (FDA) has released a guidance document dated September 2003, outlining recommendations for blood collection and transfusion facilities to report fatalities related to human blood and blood component collection or transfusion to the FDA's Center for Biologics Evaluation and Research (CBER).